United States · Artificial Intelligence (AI) startup
United States · Modulus Therapeutics
Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.
Funding reportedLast round: Seed
Follow Modulus Therapeutics and see its new rounds in your feed.Start following
What company datasets say Modulus Therapeutics raised
Funding, as reported
Reported in all$3.5Min dollars
Rounds1
Last roundSeed
Last round dateJul 2021
Investors listed3
SEC Form D$3.8M sold, 1 filing, last Jul 2021
Founders and team
From the SEC filings it signed: 2 on the team.
- Bryce R DainesExecutive Officer, Directori
- Max C DarnellExecutive Officer, Directori
On 2 portfolio pages
Investors who name them
Each firm lists Modulus Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Artificial Intelligence (AI) in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Modulus Therapeutics in front of investors. Or tell us what we have wrong.